|
Enter a Search String | Special character and space not allowed in the query term.
Search string should be at least 2 characters long. |
Molecule List for Accession CaMKII_noPKA_model3 (Accession Number62) | Default ordering is done according to Pathway Number. Table headers can be used for changing the default ordering. arrow indicates that ordering is done according to ascending or descending order. The entries are grouped according to Pathway Number and are alternately color coded using and color. |
|
Name | Pathway Name / Pathway No. | Accession Type | Initial Conc. (uM) | Volume (fL) | Buffered | Sum Total Of | 1 | NMDAR | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 120 | 0.01 | No | - | | | The stochiometry is a bit off here. Each NMDAR actually binds to a holoenzyme, about 12 CaMKII subunits. But our CaMKII calculations are in terms of individual subunits. So as a hack, we put in much more NMDAR than is actually there. | 2 | CaM | CaM
Pathway No. 259 | Network | 26.3333 | 0.09 | No | - | | There is a LOT of this in the cell: upto 1% of total protein mass. (Alberts et al) Say 25 uM. Meyer et al Science 256 1199-1202 1992 refer to studies saying it is comparable to CaMK levels. | 3 | CaM-PSD | CaM
Pathway No. 259 | Network | 26.3333 | 0.01 | No | - | | There is a LOT of this in the cell: upto 1% of total protein mass. (Alberts et al) Say 25 uM. Meyer et al Science 256 1199-1202 1992 refer to studies saying it is comparable to CaMK levels. | 4 | tot_CaMKII_cyt | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 22 | 0.09 | No | CaMKII-CaM CaMKII-thr286*-C aM CaMKII-thr286 CaMKII*** CaMK-thr305 CaMKII basal_CaMKII_ cyt
| 5 | CaMKII | CaMKII
Pathway No. 258 | Network | 20 | 0.09 | No | - | | Huge conc of CaMKII. In PSD it is 20-40% of protein, so we assume it is around 2.5% of protein in spine as a whole. This level is so high it is unlikely to matter much if we are off a bit. | 6 | I1 | PP1_PSD
Pathway No. 262 | Network | 4 | 0.01 | No | - | | I1 is a 'mixed' inhibitor, but at high enz concs it looks like a non-compet inhibitor (Foulkes et al Eur J Biochem 132 309-313 9183). We treat it as non-compet, so it just turns the enz off without interacting with the binding site. Cohen et al ann rev bioch refer to results where conc is 1.5 to 1.8 uM. In order to get complete inhib of PP1, which is at 1.8 uM, we need >= 1.8 uM. | 7 | PP1-active_PSD | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 4 | 0.01 | No | - | | | Cohen et al Meth Enz 159 390-408 is main source of info conc = 1.8 uM | 8 | basal_CaMKII_ PSD | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 2 | 0.01 | No | - | 9 | basal_CaMKII_ cyt | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 2 | 0.09 | Yes | - | 10 | basal_CaMKII_ PSD_control | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 2 | 0.01 | Yes | - | 11 | tot_autonomous_ CaMKII | CaMKII
Pathway No. 258 | Network | 2 | 0.09 | No | CaMKII-thr286 CaMKII*** basal_CaMKII_ cyt
| 12 | tot-auto-PSD | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 2 | 0.01 | No | CaMKII-thr286-PS D CaMKII***-PSD basal_CaMKII_ PSD
| 13 | actCaMKII-PSD | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 2 | 0.01 | No | CaMKII-thr286-Ca M-PSD CaMKII-CaM-PSD tot-auto-PSD
| 14 | tot_CaMKII_PSD | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 2 | 0.01 | No | actCaMKII-PSD CaMKII-PSD CaMKII-thr305-PS D
| 15 | act_CaMKII_cyt | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 2 | 0.09 | No | tot_CaM_CaMKII tot_autonomous_ CaMKII
| 16 | PP1-active | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 1.8 | 0.09 | No | - | | | Cohen et al Meth Enz 159 390-408 is main source of info conc = 1.8 uM | 17 | I1 | PP1
Pathway No. 260 | Network | 1.8 | 0.09 | No | - | | I1 is a 'mixed' inhibitor, but at high enz concs it looks like a non-compet inhibitor (Foulkes et al Eur J Biochem 132 309-313 9183). We treat it as non-compet, so it just turns the enz off without interacting with the binding site. Cohen et al ann rev bioch refer to results where conc is 1.5 to 1.8 uM. In order to get complete inhib of PP1, which is at 1.8 uM, we need >= 1.8 uM. | 18 | CaNAB | PP2B
Pathway No. 261 | Network | 1 | 0.09 | No | - | | We assume that the A and B subunits of PP2B are always bound under physiol conditions. Up to 1% of brain protein = 25 uM. I need to work out how it is distributed between cytosolic and particulate fractions. Tallant and Cheung '83 Biochem 22 3630-3635 have conc in many species, average for mammalian brain is around 1 uM. | 19 | PP2A | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 0.1111 | 0.09 | No | - | 20 | Ca | Shared_Object_ CaMKII_noPKA_ model3 Pathway No. 257Network | 0.08 | 0.09 | No | - | | | | | | | | | | |
| Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details. |
|